Q01114
Gene name |
Il9r |
Protein name |
Interleukin-9 receptor |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:16199 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for Q01114
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 8DDD | NMR | - | B | 268-298 | PDB |
| AF-Q01114-F1 | Predicted | AlphaFoldDB |
49 variants for Q01114
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389153846 | 2 | A>* | No | EVA | |
| rs3389146678 | 2 | A>V | No | EVA | |
| rs243382053 | 8 | A>V | No | EVA | |
| rs232950109 | 17 | A>T | No | EVA | |
| rs260186884 | 29 | W>C | No | EVA | |
| rs254366318 | 38 | V>I | No | EVA | |
| rs3401818634 | 50 | A>D | No | EVA | |
| rs251913050 | 52 | A>T | No | EVA | |
| rs48507356 | 68 | S>L | No | EVA | |
| rs3389086833 | 75 | E>V | No | EVA | |
| rs214433136 | 88 | T>A | No | EVA | |
| rs47492407 | 91 | K>N | No | EVA | |
| rs238816843 | 95 | T>I | No | EVA | |
| rs3389120627 | 96 | F>I | No | EVA | |
| rs3389146666 | 120 | T>R | No | EVA | |
| rs3389148068 | 123 | R>C | No | EVA | |
| rs231914282 | 156 | V>I | No | EVA | |
| rs3389149450 | 167 | I>T | No | EVA | |
| rs50540382 | 179 | S>N | No | EVA | |
| rs3389144164 | 185 | K>M | No | EVA | |
| rs3389146668 | 189 | E>* | No | EVA | |
| rs3389149405 | 194 | R>G | No | EVA | |
| rs224243234 | 200 | V>F | No | EVA | |
| rs3389145403 | 201 | G>R | No | EVA | |
| rs261022887 | 210 | V>I | No | EVA | |
| rs249160717 | 217 | I>V | No | EVA | |
| rs108334533 | 227 | T>S | No | EVA | |
| rs46823302 | 230 | S>R | No | EVA | |
| rs3402303052 | 236 | E>Q | No | EVA | |
| rs3389135656 | 239 | Y>F | No | EVA | |
| rs3389140561 | 247 | W>L | No | EVA | |
| rs49750132 | 259 | R>T | No | EVA | |
| rs3389120611 | 268 | Q>K | No | EVA | |
| rs240904033 | 276 | V>I | No | EVA | |
| rs3411452391 | 277 | V>M | No | EVA | |
| rs254063050 | 289 | L>I | No | EVA | |
| rs3389086797 | 292 | K>T | No | EVA | |
| rs29461035 | 297 | L>V | No | EVA | |
| rs262257140 | 305 | I>T | No | EVA | |
| rs265162327 | 325 | S>T | No | EVA | |
| rs246861519 | 330 | R>H | No | EVA | |
| rs3389157049 | 351 | S>N | No | EVA | |
| rs226922170 | 356 | V>I | No | EVA | |
| rs3389140619 | 383 | G>E | No | EVA | |
| rs229369086 | 384 | L>P | No | EVA | |
| rs260557177 | 393 | A>T | No | EVA | |
| rs241037623 | 450 | E>Q | No | EVA | |
| rs3389120688 | 464 | V>M | No | EVA | |
| rs3402116826 | 466 | S>R | No | EVA |
No associated diseases with Q01114
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| cell surface | The external part of the cell wall and/or plasma membrane. |
| external side of plasma membrane | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| cytokine receptor activity | Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| interleukin-9 binding | Binding to interleukin-9. |
| interleukin-9 receptor activity | Combining with interleukin-9 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| B cell differentiation | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
| B cell proliferation | The expansion of a B cell population by cell division. Follows B cell activation. |
| cytokine-mediated signaling pathway | The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| immunoglobulin mediated immune response | An immune response mediated by immunoglobulins, whether cell-bound or in solution. |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. |
| positive regulation of cell growth | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| regulation of peptidyl-tyrosine phosphorylation | Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
4 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P14753 | Epor | Erythropoietin receptor | Mus musculus (Mouse) | PR |
| Q08351 | Mpl | Thrombopoietin receptor | Mus musculus (Mouse) | PR |
| P26954 | Csf2rb2 | Interleukin-3 receptor class 2 subunit beta | Mus musculus (Mouse) | PR |
| P26955 | Csf2rb | Cytokine receptor common subunit beta | Mus musculus (Mouse) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MALGRCIAEG | WTLERVAVKQ | VSWFLIYSWV | CSGVCRGVSV | PEQGGGGQKA | GAFTCLSNSI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| YRIDCHWSAP | ELGQESRAWL | LFTSNQVTEI | KHKCTFWDSM | CTLVLPKEEV | FLPFDNFTIT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LHRCIMGQEQ | VSLVDSQYLP | RRHIKLDPPS | DLQSNVSSGR | CVLTWGINLA | LEPLITSLSY |
| 190 | 200 | 210 | 220 | 230 | 240 |
| ELAFKRQEEA | WEARHKDRIV | GVTWLILEAV | ELNPGSIYEA | RLRVQMTLES | YEDKTEGEYY |
| 250 | 260 | 270 | 280 | 290 | 300 |
| KSHWSEWSQP | VSFPSPQRRQ | GLLVPRWQWS | ASILVVVPIF | LLLTGFVHLL | FKLSPRLKRI |
| 310 | 320 | 330 | 340 | 350 | 360 |
| FYQNIPSPEA | FFHPLYSVYH | GDFQSWTGAR | RAGPQARQNG | VSTSSAGSES | SIWEAVATLT |
| 370 | 380 | 390 | 400 | 410 | 420 |
| YSPACPVQFA | CLKWEATAPG | FPGLPGSEHV | LPAGCLELEG | QPSAYLPQED | WAPLGSARPP |
| 430 | 440 | 450 | 460 | ||
| PPDSDSGSSD | YCMLDCCEEC | HLSAFPGHTE | SPELTLAQPV | ALPVSSRA |